Earth Life Sciences Inc.
CLTS
$0.00
$0.000.00%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.12% | 5,777.78% | -97.99% | -- | 73.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.12% | 5,777.78% | -97.99% | -- | 73.20% |
| Operating Income | -10.12% | -5,777.78% | 97.99% | -- | -73.20% |
| Income Before Tax | 6.70% | -2,827.27% | 97.66% | -- | -130.93% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 6.70% | -2,827.27% | 97.66% | -- | -130.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.70% | -2,827.27% | 97.66% | -- | -130.93% |
| EBIT | -10.12% | -5,777.78% | 97.99% | -- | -73.20% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -- | -- | 100.00% | -- | -- |
| Normalized Basic EPS | -- | -- | 100.00% | -- | -- |
| EPS Diluted | -- | -- | 100.00% | -- | -- |
| Normalized Diluted EPS | -- | -- | 100.00% | -- | -- |
| Average Basic Shares Outstanding | 96.24% | 106.28% | 0.00% | 7.99% | 12.81% |
| Average Diluted Shares Outstanding | 96.24% | 106.28% | 0.00% | 7.99% | 12.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
